The law firm advised on its CHF 525 m syndicated credit facilities linked to sustainability targets. The Homburger team was led by associate David Borer (pictured left) and partner Hansjürg Appenzeller (pictured right) (both Financing
Tags :Homburger
The law firm assisted on its issuance of EUR 850,000,000 0.500 per cent. sustainability-linked notes due 2031. The team was led by partner Daniel Daeniker (Corporate / M&A and Capital Markets - pictured) and included partner Stefan Oesterhelt (
The team was led by partner Daniel Hasler (Corporate / M&A - pictured) and included partner Reto Heuberger (Tax) as well as associates Timo Hasler (Corporate / M&A) and Marc Vogelsang (Tax).
The firm advises the holding on its restructuring consisting of CHF 500 m new funding provided by the shareholders, CHF 200 m senior secured interim liquidity facility extended by shareholders and extension of the maturity of the
Richard Stäuber (pictured), partner in Homburger’s competition and regulatory practice group, has been appointed Non-Governmental Advisor to the Swiss Competition Commission for the International Competition Network (ICN) for the coming three years.
The firm advised UBS Group on its issuance of EUR 1.5 bn Fixed Rate/Fixed Rate Callable Senior Notes under its Senior Debt Programme. The team included partners Benedikt Maurenbrecher (pictured), Stefan Kramer (both Banking and
Homburger acted as a legal counsel to Winemaker in connection with the setting-up of its business. The team was led by partners Claude Lambert (Corporate/M&A - pictured), Luca Dal Molin (IP/IT) and
Homburger acted as legal advisor to Baker Hughes in this matter. The responsible partner was Claude Lambert (Corporate | M&A - pictured) and the team, led by associate Daniel Häusermann (Corporate | M&A), included
The law firm advised in connection with a collaboration with Novartis to develop DARPin® therapies designed for potential use against Covid-19. The team was led by partner Dieter Gericke (Corporate/ M&A, Capital Markets -
Homburger advises VectivBio on USD 110 m crossover financing.The team was led by partner Andreas Müller (pictured left). Walder Wyss advised BPI France, Cowen Healthcare Investments, Novo Ventures, OrbiMed and Versant Ventures as lead
